on Invasive Cancer Test (NICT) : a pilot study

Recruiting

• Conditions: cancer; 10027656

• Registration Number: NL-OMON50225
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Patients with newly diagnosed breast cancer, colorectal cancer, non-small cell
lung cancer or glioblastoma, Patients age > 18 years, willing and able to
comply with the protocol as judged by the investigator with a signed informed
consent

Exclusion Criteria

Patients with a history of malignant disease other than the disease under
study, with an exception for adequately treated squamous cell carcinoma of the
skin, basal cell carcinoma of the skin and in situ cervix carcinoma.
Pregnancy

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Presence of ctDNA in the circulation<br /><br>NICT/Chromosome aneuploidy profile</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>